In vitro toxicity assessment of chitosan nanoparticles
Abstract
[Truncated abstract] Nascent research into nanomaterial toxicity indicates significant deviations from the parent material, with concerns regarding the potential of nanomaterials to cross biological barriers and enter into cells and organelles due to their small size. This thesis sets out to prove the hypothesis that chitosan nanoparticles could induce cytotoxicity in human intestinal and liver cells. Chitosan nanoparticles were evaluated because extensive research into their biomedical applications was based largely on the biodegradable and biocompatible profile of chitosan. In order to evaluate cytotoxicity, a novel method for the reproducible fabrication of a continual supply of chitosan nanoparticles (NP) was first developed using the spinning disc processing (SDP) technology. NP with a diameter of 20 ± 3 nm and zeta potential of 53.3 ± 4.3 mV were successfully produced, and were comparable to those produced by the conventional method. Particle size was modulated by the type and concentration of acid used in the chitosan feed solution. NP following dialysis and lyophilisation were stable in size when stored in the dry state at -20 C for up to 2 months. Dispersion of the lyophilised NP into various biorelevant media affected particle size, zeta potential and aggregation status. NP particle size was preserved in Hanks balanced salt solution and supplemented culture media, although protein adsorption in the latter caused the NP to assume a negative zeta potential. Evidence…
How strong is the evidence?
Evidence Hub reads this as a thesis, done in cell cultures (in vitro), not in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Quantum dots: synthesis, bioapplications, and toxicity
- A Guide to In Silico Drug Design
- Quantum Computing for Healthcare: A Review
- Automated in Silico Design of Homogeneous Catalysts
- Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
- In silico structural elucidation of RNA-dependent RNA polymerase towards the identification of potential Crimean-Congo Hemorrhagic Fever Virus inhibitors
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.